Submission Details
| 510(k) Number | K160793 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | March 23, 2016 |
| Decision Date | August 17, 2016 |
| Days to Decision | 147 days |
| Submission Type | Traditional |
| Review Panel | Toxicology (TX) |
| Summary | Summary PDF |
K160793 is an FDA 510(k) clearance for the First Sign Drug of Abuse Dip Card Test (MDMA, EDDP, Nortriptyline), First Sign Drug of Abuse Cup Test (MDMA, EDDP, Nortriptyline), a Enzyme Immunoassay, Methadone (Class II — Special Controls, product code DJR), submitted by W.H.P.M., Inc. (Irwindale, US). The FDA issued a Cleared decision on August 17, 2016, 147 days after receiving the submission on March 23, 2016. This device falls under the Toxicology review panel. Regulated under 21 CFR 862.3620.
| 510(k) Number | K160793 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | March 23, 2016 |
| Decision Date | August 17, 2016 |
| Days to Decision | 147 days |
| Submission Type | Traditional |
| Review Panel | Toxicology (TX) |
| Summary | Summary PDF |
| Product Code | DJR — Enzyme Immunoassay, Methadone |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 862.3620 |